A detailed history of Oppenheimer Asset Management Inc. transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 45,473 shares of MEDP stock, worth $14.1 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
45,473
Previous 42,798 6.25%
Holding current value
$14.1 Million
Previous $17.6 Million 13.97%
% of portfolio
0.19%
Previous 0.23%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$320.58 - $457.29 $857,551 - $1.22 Million
2,675 Added 6.25%
45,473 $15.2 Million
Q2 2024

Aug 08, 2024

BUY
$372.0 - $424.34 $1.55 Million - $1.77 Million
4,168 Added 10.79%
42,798 $17.6 Million
Q1 2024

May 06, 2024

SELL
$284.87 - $413.31 $1.77 Million - $2.57 Million
-6,211 Reduced 13.85%
38,630 $15.6 Million
Q4 2023

Feb 13, 2024

BUY
$227.52 - $312.68 $3.12 Million - $4.29 Million
13,725 Added 44.11%
44,841 $13.7 Million
Q3 2023

Nov 07, 2023

SELL
$233.98 - $281.67 $447,603 - $538,834
-1,913 Reduced 5.79%
31,116 $7.53 Million
Q2 2023

Aug 02, 2023

BUY
$187.26 - $240.17 $1.97 Million - $2.53 Million
10,546 Added 46.91%
33,029 $7.93 Million
Q1 2023

May 10, 2023

SELL
$174.31 - $239.52 $207,603 - $285,268
-1,191 Reduced 5.03%
22,483 $4.23 Million
Q4 2022

Feb 06, 2023

SELL
$153.06 - $226.57 $383,262 - $567,331
-2,504 Reduced 9.57%
23,674 $5.03 Million
Q3 2022

Nov 14, 2022

SELL
$145.13 - $182.49 $283,148 - $356,037
-1,951 Reduced 6.94%
26,178 $4.11 Million
Q2 2022

Aug 08, 2022

BUY
$130.2 - $168.03 $556,605 - $718,328
4,275 Added 17.92%
28,129 $4.21 Million
Q1 2022

May 12, 2022

SELL
$138.87 - $214.31 $413,277 - $637,786
-2,976 Reduced 11.09%
23,854 $3.9 Million
Q4 2021

Feb 02, 2022

BUY
$182.74 - $227.9 $530,494 - $661,593
2,903 Added 12.13%
26,830 $5.84 Million
Q3 2021

Nov 12, 2021

BUY
$170.18 - $198.21 $138,696 - $161,541
815 Added 3.53%
23,927 $4.53 Million
Q2 2021

Aug 03, 2021

BUY
$158.62 - $194.3 $54,565 - $66,839
344 Added 1.51%
23,112 $4.08 Million
Q1 2021

May 17, 2021

BUY
$132.02 - $168.26 $739,444 - $942,424
5,601 Added 32.63%
22,768 $3.74 Million
Q4 2020

Feb 11, 2021

BUY
$109.38 - $149.19 $386,439 - $527,088
3,533 Added 25.91%
17,167 $2.39 Million
Q3 2020

Nov 13, 2020

BUY
$92.95 - $130.61 $95,459 - $134,136
1,027 Added 8.15%
13,634 $1.52 Million
Q2 2020

Aug 11, 2020

BUY
$68.08 - $95.68 $175,237 - $246,280
2,574 Added 25.66%
12,607 $1.17 Million
Q1 2020

May 08, 2020

BUY
$61.71 - $101.95 $253,936 - $419,524
4,115 Added 69.53%
10,033 $736,000
Q4 2019

Feb 07, 2020

BUY
$70.08 - $84.64 $43,729 - $52,815
624 Added 11.79%
5,918 $497,000
Q3 2019

Oct 31, 2019

SELL
$62.38 - $85.89 $66,185 - $91,129
-1,061 Reduced 16.7%
5,294 $445,000
Q2 2019

Aug 09, 2019

BUY
$53.64 - $65.42 $112,375 - $137,054
2,095 Added 49.18%
6,355 $416,000
Q1 2019

Apr 24, 2019

BUY
$49.38 - $70.58 $25,529 - $36,489
517 Added 13.81%
4,260 $251,000
Q4 2018

Jan 30, 2019

BUY
$46.97 - $63.98 $175,808 - $239,477
3,743 New
3,743 $198,000
Q4 2017

Feb 07, 2018

SELL
$32.46 - $38.31 $1,785 - $2,107
-55 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$27.43 - $33.11 $1,508 - $1,821
55
55 $2,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $9.66B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Oppenheimer Asset Management Inc. Portfolio

Follow Oppenheimer Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.